X0609 4 2026-05-15 0 0001826667 TriSalus Life Sciences, Inc. TLSI 0001424204 Stansky Michael P false 6272 W. 91ST AVENUE WESTMINSTER CO 80031 1 0 0 0 0 Common Stock 2026-05-15 4 P 0 410000 2.50 A 1240722 D Common Stock 2026-05-15 4 P 0 200000 2.50 A 399698 I By Skyview Investments LLC The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.47 to $2.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. The securities reported herein are owned by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member. /s/ Mary Szela, Attorney-in-Fact 2026-05-18